| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 03/24/2005 | WO2005026168A1 Method for preparing cucurbiturils |
| 03/24/2005 | WO2004110990A3 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 |
| 03/24/2005 | WO2004085421A3 Bioreductively-activated prodrugs |
| 03/24/2005 | US20050065341 Substituted 8-heteroaryl xanthines |
| 03/24/2005 | US20050065164 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 03/24/2005 | CA2537843A1 Method for preparing cucurbiturils |
| 03/23/2005 | EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 03/23/2005 | EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | CA2125189C Pyropheophorbides and their use in photodynamic therapy |
| 03/17/2005 | WO2005023819A1 Thienopyrroles as antiviral agents |
| 03/17/2005 | WO2005023816A2 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compouds and uses thereof |
| 03/17/2005 | WO2005023806A2 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands |
| 03/17/2005 | WO2005023255A2 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 03/17/2005 | US20050059628 Modulation of beta-catenin/TCF-activated transcription |
| 03/17/2005 | CA2537829A1 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands |
| 03/17/2005 | CA2537752A1 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 03/17/2005 | CA2537736A1 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof |
| 03/17/2005 | CA2537545A1 Thienopyrroles as antiviral agents |
| 03/16/2005 | EP1513848A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1425283B1 Novel 4-aminofuropyrimidines and the use thereof |
| 03/16/2005 | EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/16/2005 | EP0808164B1 Use of prolactin modulators and diet for the manufacture of a medicament for the treatment of obesity |
| 03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 03/15/2005 | US6867300 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 03/15/2005 | US6867200 Anticancer agents; anticoagulants |
| 03/15/2005 | CA2146852C New substituted pyrazole derivatives, processes for their preparation and their use as herbicides |
| 03/15/2005 | CA2086914C Quinolone-and naphthyridone-carboxylic acid derivatives |
| 03/10/2005 | WO2005021548A2 Substituted 8-heteroaryl xanthines |
| 03/10/2005 | WO2005021025A2 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 03/10/2005 | WO2005020987A1 Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity |
| 03/10/2005 | WO2005020894A2 Rifamycin analogs and uses thereof |
| 03/10/2005 | US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 03/10/2005 | US20050054672 Quinolinone derivatives |
| 03/10/2005 | CA2537099A1 Modulation of .beta.-catenin/tcf activated transcription |
| 03/10/2005 | CA2536553A1 Substituted 8-heteroaryl xanthines |
| 03/10/2005 | CA2536378A1 Rifamycin analogs and uses thereof |
| 03/09/2005 | EP1512688A1 Use of K-252a derivatives for the treatment of Parkinson's disease |
| 03/09/2005 | EP1512403A1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 03/09/2005 | EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 03/09/2005 | EP1511492A2 Protease inhibitors |
| 03/09/2005 | CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 03/09/2005 | CN1592624A Substituted-triazolopyrimidines as anticancer agents |
| 03/08/2005 | CA2153239C 5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine-2(3h)-thione compounds and their use in the preparation of 2,2'-dithiobis(5-alkoxy[1,2,4]triazolo[1,5-c]-pyrimidine) and 2-chlorosulfonyl-5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine compounds |
| 03/03/2005 | WO2004104004A3 Triaza-spiro compounds as nociceptin analogues and uses thereof |
| 03/03/2005 | WO2004104001A3 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 03/03/2005 | WO2003031405A3 Methods for the synthesis of substituted purines |
| 03/03/2005 | US20050049260 2-phenyl-4-pyridinyl- or -pyrimidinyl derivatives, e.g., N-Cyclopentyl-3-[2-(cyclopentylamino)-4-pyrimidinyl]-2-(4-methoxyphenyl)-pyrazolo[1,5-a]pyridin-7-amine and; especially for treatment of herpes simplex virus 1 and 2 |
| 03/03/2005 | US20050049250 7-Aikyl and cycloalkyl-substituted imidazotriazinones |
| 03/02/2005 | EP1509522A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 03/02/2005 | EP1165563B1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 03/02/2005 | EP1073661B1 Dioxazine derivatives and their use as dyestuffs |
| 03/02/2005 | CN1589273A The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/01/2005 | US6861430 β-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 03/01/2005 | US6861427 For therapy of cognitive deficits due to aging, stroke, head trauma, Alzheimer's disease or other neurodegenerative diseases, or schizophrenia, anxiety, aggression and stress, eating disorder, sleep disorder, sexual dysfunction |
| 03/01/2005 | US6861422 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 02/24/2005 | US20050043323 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/24/2005 | US20050043298 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 3'-hydroxy-5'-(4-ethylcarbamyl-1-piperidinyl)benzoxazinorifamycin |
| 02/24/2005 | US20050043242 Using dietary restriction to lower serum insulin levels and function along with troglitazone in treatment and prevention of alzheimer's diseases |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050041494 High density non-volatile memory device |
| 02/23/2005 | EP1507778A1 Anti-tumour polycyclic carboxamides |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1583759A Preparing method for nanometer powder of synthetic metal ET salt |
| 02/23/2005 | CN1583758A Use of Maituolaicin |
| 02/23/2005 | CN1190440C Triazolo-epothilones |
| 02/22/2005 | US6858613 Central nervous system disorders |
| 02/17/2005 | WO2005014600A1 Antagonists of mcp-1 function and methods of use thereof |
| 02/17/2005 | WO2005014599A1 Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds |
| 02/17/2005 | WO2005014581A2 Lanthanide complexes preparation and uses thereof |
| 02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2004096982A3 Antibacterial agents |
| 02/17/2005 | US20050038088 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/17/2005 | CA2535125A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2534496A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2533698A1 Lanthanide complexes preparation and uses thereof |
| 02/16/2005 | EP1506192A1 Substituted pyrroline kinase inhibitors |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | CN1580055A Quinolone carboxylic acid derivatives and their salts |
| 02/15/2005 | US6855724 Tropane derivatives useful in therapy |
| 02/10/2005 | WO2005012311A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/10/2005 | US20050033048 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 02/10/2005 | US20050032860 CBI analogs of CC-1065 and the duocarmycins |
| 02/10/2005 | US20050032820 Novel spiro compounds |
| 02/10/2005 | US20050032817 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 02/10/2005 | CA2532382A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/09/2005 | EP1505068A1 PYRAZOLO (1,5-a) PYRIMIDINE DERIVATIVE AND NAD(P)H OXIDASE INHIBITOR CONTAINING THE SAME |
| 02/09/2005 | EP1504010A1 Vitamin-mitomycin conjugates |
| 02/09/2005 | EP1503760A1 Camptothecin derivatives and polymeric conjugates thereof |
| 02/09/2005 | EP1280805B1 Novel imidazotriazinones and the use thereof |
| 02/08/2005 | US6852731 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses |
| 02/03/2005 | WO2005010006A1 Substituted furochromene compounds of antiinflammatory action |
| 02/03/2005 | WO2004083175A3 Methods for identifying enzyme inhibitors and protein kinases |
| 02/03/2005 | US20050026941 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 02/03/2005 | US20050026921 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/03/2005 | US20050026901 Antihistaminic spiro compounds |
| 02/03/2005 | CA2533584A1 Substituted furochromene compounds of antiinflammatory action |